First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Sagittarius Trial
- Status
- RECRUITING
- Phase
- PHASE3
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE2
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE3
Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
- Status
- RECRUITING
- Phase
- PHASE4
Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
- Status
- RECRUITING
- Phase
- PHASE1